Cape Regional Urgent Care, New Jersey
Objective
The objective was to determine whether the Defend 400 air cleaner could reduce airborne bacterial counts as compared to the control (no Defend device) in an urgent care outpatient facility running under normal conditions (occupied by doctors, nurses, staff and patients).
Click here to read the summary.
Methodology
Enumeration and identification of airborne bacterial species from air samples. The samples were collected using an impaction air sampler, MAS-100 Eco Microbiological Air Sampler (MBV AG, Switzerland). Bacterial counts and bacterial species identification were performed by EMSL Analytical Inc (NJ, USA).
Air samples were taken during two phases: control and test.
Both, control, and test phase conditions reported a comparable overall number of visitors (303 v 306) to the clinic, with the same average and a median number of visitors per hour (5).
Summary of Results
Compared to the control, the Defend 400:
Conclusion and Discussion
During the 5 consecutive days, the Defend 400 significantly reduced the total bacterial count by 52%, which included a 60% reduction in opportunistic pathogens and a 43% reduction in pathogenic bacteria.
Because of the reduction in bacteria, the Defend 400 complements existing infection prevention practices such as built-in heating/air conditioning systems, social distancing, hand and surface disinfection, and the use of masks.
Reduction in airborne pathogens may, in turn, decrease transmission of airborne transmitted infectious diseases at healthcare institutions, although further studies are required to demonstrate this.
Get news and updates about Novaerus and indoor air quality.